Copyright Reports & Markets. All rights reserved.

Global Drug of Abuse Testing Market Professional Survey Report 2018

Buy now

Table of Contents

    Global Drug of Abuse Testing Market Professional Survey Report 2017

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Drug of Abuse Testing Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Analysis by Types

      • 2.1 Overall Market Performance(Volume)
        • 2.1.1 Onsite Screening Test Market Performance (Volume)
        • 2.1.2 Laboratory Drug Testing Market Performance (Volume)
      • 2.2 Overall Market Performance(Value)
        • 2.1.1 Onsite Screening Test Market Performance (Value)
        • 2.1.2 Laboratory Drug Testing Market Performance (Value)

      3 Product Application Market

      • 3.1 Overall Market Performance (Volume)
        • 3.1.1 Urine Market Performance (Volume)
        • 3.1.2 Hair Market Performance (Volume)
        • 3.1.3 Saliva Market Performance (Volume)

      4 Manufacturers Profiles/Analysis

      • 4.1 Roche Holding Limited
        • 4.1.1 Roche Holding Limited Profiles
        • 4.1.2 Roche Holding Limited Product Information
        • 4.1.3 Roche Holding Limited Drug of Abuse Testing Business Performance
        • 4.1.4 Roche Holding Limited Drug of Abuse Testing Business Development and Market Status
      • 4.2 Quest Diagnostics
        • 4.2.1 Quest Diagnostics Profiles
        • 4.2.2 Quest Diagnostics Product Information
        • 4.2.3 Quest Diagnostics Drug of Abuse Testing Business Performance
        • 4.2.4 Quest Diagnostics Drug of Abuse Testing Business Development and Market Status
      • 4.3 Laboratory Corporation of America Holdings
        • 4.3.1 Laboratory Corporation of America Holdings Profiles
        • 4.3.2 Laboratory Corporation of America Holdings Product Information
        • 4.3.3 Laboratory Corporation of America Holdings Drug of Abuse Testing Business Performance
        • 4.3.4 Laboratory Corporation of America Holdings Drug of Abuse Testing Business Development and Market Status
      • 4.4 Alere Inc
        • 4.4.1 Alere Inc Profiles
        • 4.4.2 Alere Inc Product Information
        • 4.4.3 Alere Inc Drug of Abuse Testing Business Performance
        • 4.4.4 Alere Inc Drug of Abuse Testing Business Development and Market Status
      • 4.5 Abbott Laboratories
        • 4.5.1 Abbott Laboratories Profiles
        • 4.5.2 Abbott Laboratories Product Information
        • 4.5.3 Abbott Laboratories Drug of Abuse Testing Business Performance
        • 4.5.4 Abbott Laboratories Drug of Abuse Testing Business Development and Market Status
      • 4.6 Randox Laboratories
        • 4.6.1 Randox Laboratories Profiles
        • 4.6.2 Randox Laboratories Product Information
        • 4.6.3 Randox Laboratories Drug of Abuse Testing Business Performance
        • 4.6.4 Randox Laboratories Drug of Abuse Testing Business Development and Market Status
      • 4.7 Psychemedics Corporation
        • 4.7.1 Psychemedics Corporation Profiles
        • 4.7.2 Psychemedics Corporation Product Information
        • 4.7.3 Psychemedics Corporation Drug of Abuse Testing Business Performance
        • 4.7.4 Psychemedics Corporation Drug of Abuse Testing Business Development and Market Status
      • 4.8 Bio-Rad Laboratories
        • 4.8.1 Bio-Rad Laboratories Profiles
        • 4.8.2 Bio-Rad Laboratories Product Information
        • 4.8.3 Bio-Rad Laboratories Drug of Abuse Testing Business Performance
        • 4.8.4 Bio-Rad Laboratories Drug of Abuse Testing Business Development and Market Status
      • 4.9 Sonic Healthcare
        • 4.9.1 Sonic Healthcare Profiles
        • 4.9.2 Sonic Healthcare Product Information
        • 4.9.3 Sonic Healthcare Drug of Abuse Testing Business Performance
        • 4.9.4 Sonic Healthcare Drug of Abuse Testing Business Development and Market Status
      • 4.10 Thermo Fisher Scientific Inc
        • 4.10.1 Thermo Fisher Scientific Inc Profiles
        • 4.10.2 Thermo Fisher Scientific Inc Product Information
        • 4.10.3 Thermo Fisher Scientific Inc Drug of Abuse Testing Business Performance
        • 4.10.4 Thermo Fisher Scientific Inc Drug of Abuse Testing Business Development and Market Status

      5 Market Performance for Manufacturers

      • 5.1 Global Drug of Abuse Testing Capacity (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Drug of Abuse Testing Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Drug of Abuse Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.4 Global Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
      • 5.5 Global Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
      • 5.6 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 China Market Performance for Manufacturers
        • 6.1.1 China Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 China Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 China Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 China Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 USA Market Performance for Manufacturers
        • 6.2.1 USA Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 USA Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 USA Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 USA Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Europe Market Performance for Manufacturers
        • 6.3.1 Europe Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Europe Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Europe Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Europe Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 Japan Market Performance for Manufacturers
        • 6.4.1 Japan Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 Japan Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 Japan Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 Japan Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Korea Market Performance for Manufacturers
        • 6.5.1 Korea Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Korea Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Korea Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Korea Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration
      • 6.6 India Market Performance for Manufacturers
        • 6.6.1 India Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.6.2 India Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.6.3 India Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.6.4 India Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.6.5 Market Concentration
      • 6.7 Southeast Asia Market Performance for Manufacturers
        • 6.7.1 Southeast Asia Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.7.2 Southeast Asia Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.7.3 Southeast Asia Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.7.4 Southeast Asia Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.7.5 Market Concentration
      • 6.8 South America Market Performance for Manufacturers
        • 6.8.1 South America Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.8.2 South America Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.8.3 South America Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
        • 6.8.4 South America Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
        • 6.8.5 Market Concentration

      7 Global Drug of Abuse Testing Market Performance (Sales Point)

      • 7.1 Global Drug of Abuse Testing Capacity (K Units) and Market Share by Regions 2013-2018
      • 7.2 Global Drug of Abuse Testing Sales (K Units) and Market Share by Regions 2013-2018
      • 7.3 Global Drug of Abuse Testing Revenue (M USD) and Market Share by Regions 2013-2018
      • 7.4 Global Drug of Abuse Testing Price (USD/Unit) by Regions 2013-2018
      • 7.5 Global Drug of Abuse Testing Gross Margin by Regions 2013-2018

      8 Development Trend for Regions (Sales Point)

      • 8.1 Global Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.2 China Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.3 USA Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.4 Europe Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.5 Japan Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.6 Korea Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.7 India Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.8 Southeast Asia Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.9 Southeast Asia Drug of Abuse Testing Capacity and Growth, Sales Value and Growth Rate2013-2018

      9 Development Trend for Regions (Sales Point)

      • 9.1 Global Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.2 China Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.3 USA Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.4 Europe Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.5 Japan Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.6 Korea Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.7 India Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.8 Southeast Asia Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.9 South America Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018

      10 Upstream Source, Technology and Cost

      • 10.1 Upstream Source
      • 10.2 Technology
      • 10.3 Cost

      11 Channel Analysis

      • 11.1 Market Channel
      • 11.2 Distributors

      12 Consumer Analysis

      • 12.1 Urine Industry
      • 12.2 Hair Industry
      • 12.3 Saliva Industry

      13 Market Forecast 2019-2024

      • 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        • 13.1.1 Global Drug of Abuse Testing Capacity (K Units) and Share by Regions 2019-2024
        • 13.1.2 Global Drug of Abuse Testing Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
        • 13.1.3 China Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.4 USA Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.5 Europe Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.6 Japan Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.7 Korea Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.8 India Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.9 Southeast Asia Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.10 South America Drug of Abuse Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        • 13.3.1 Overall Market Performance
        • 13.3.2 Onsite Screening Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.3 Laboratory Drug Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.4 Sales by Application 2019-2024
        • 13.4.1 Overall Market Performance
        • 13.4.2 Urine Sales and and Growth Rate 2019-2024
        • 13.4.3 Hair Sales and and Growth Rate 2019-2024
        • 13.4.4 Saliva Sales and and Growth Rate 2019-2024
      • 13.5 Price (USD/Unit) and Gross Profit
        • 13.5.1 Global Drug of Abuse Testing Price (USD/Unit) Trend 2019-2024
        • 13.5.2 Global Drug of Abuse Testing Gross Profit Trend 2019-2024

      14 Conclusion

      This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
      Roche Holding Limited
      Quest Diagnostics
      Laboratory Corporation of America Holdings
      Alere Inc
      Abbott Laboratories
      Randox Laboratories
      Psychemedics Corporation
      Bio-Rad Laboratories
      Sonic Healthcare
      Thermo Fisher Scientific Inc
      ...

      On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
      Onsite Screening Test
      Laboratory Drug Testing

      By Application, the market can be split into
      China
      USA
      Europe
      Japan
      Korea
      India
      Southeast Asia
      South America

      By Regions, this report covers (we can add the regions/countries as you want)

      If you have any special requirements, please let us know and we will offer you the report as you want.

      Buy now